A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer

Patrizia Chiusolo, Claudia Marchetti, Monica Rossi, Gessica Minnella, Vanda Salutari, Mariagrazia Distefano, Sabrina Giammarco, Elisabetta Metafuni, Angelo Minucci, Filippo Frioni, Cristiana Gasbarrino, Maria Colangelo, Daniela Orteschi, Anna Fagotti, Domenica Lorusso, Livio Pagano, Valerio De Stefano, Giovanni Scambia, Simona Sica

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)E400-E403
JournalAmerican Journal of Hematology
Volume97
DOIs
Publication statusPublished - 2022

Keywords

  • Female
  • Humans
  • Leukemia, Myeloid, Acute
  • Mutation
  • Myelodysplastic Syndromes
  • Ovarian Neoplasms
  • Poly(ADP-ribose) Polymerase Inhibitors

Cite this